Albert David Ltd Financial Statement - Albert David Ltd Balance Sheet | Research 360 by Motilal Oswal
15:59 Apr 19

Albert David Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1125.30
-3.20 (-0.28%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Albert David Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1125.30
-3.20 (-0.28%)
15:59 Apr 19
Quality
image/svg+xml

61/100
High Financial Strength

Valuation
image/svg+xml

63/100
Affordable Valuation

Technical

56/100
Technically Neutral

Strength

7

Weakness

1

Opportunity

2

Threats

3

11.61 %

ROE %

8.54 %

ROA %

63.39

EPS

545.93

BVPS

0.00 %

Net Profit Margin

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM 2023
Net Sales
320.8 247.45 313.51 341.56 354.83
Operating Expenses +
290.48 228.31 272.72 297.22 307.94
Raw Material
108.42 82.87 112.56 127.69 124.84
Increase Decrease in Cost
-3.03 3.3 2.38 -4.6 1.73
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
90.34 82.7 85.38 81.07 82.95
Miscellaneous Expenses
199.39 151.68 194.6 221.36 98.42
Operating Profit
30.32 19.14 40.79 44.34 46.89
Other Income
7.11 17.18 15.84 15.4 47.12
Depreciation
7.67 8.23 8.81 8.55 7.29
Interest
0.8 0.65 0.53 0.46 0.37
Profit before tax and exceptio..
28.95 27.44 47.3 50.74 86.35
Exceptional Items
0 0 0 0 0
PBT
28.95 27.44 47.3 50.74 86.35
Provision for Taxation
9.79 5.3 12.04 14.56 20.13
Net Profit
19.17 22.14 35.26 36.17 66.24
NET Profit after MI
0 0 0 0 0
EPS
33.59 38.8 61.78 63.39 116.07
Operating Profit Margin (%)
9.45 7.73 13.01 12.98 13.21
Net Profit Margin (%)
5.98 8.95 11.25 10.59 18.67

ShareHolding

All Data in Percentage (%)

Mar 24 Dec 23 Sep 23 Jun 23 Mar 23
Promoter 62.10 62.00 62.00 62.00 62.00
FII 1.00 0.70 0.60 0.60 0.60
MF 0.00 0.00 0.00 0.00 0.00
Public 35.20 35.60 35.50 35.00 34.60
Others 1.70 1.70 1.90 2.40 2.80
Shareholder Shares Holding %

Download Our App On: